ELDA BrainTech
EEG and fMRI AI-powered Neurodiagnostic Platform
Company Overview
Snapshot
Founded in November 2019 by Dan Shaham, ELDA BrainTech operates with 1–10 employees. The company has obtained FDA pre-submission approval, positioning its AI-powered neurodiagnostic platform for deployment in epilepsy clinical centers globally.
Business overview
ELDA BrainTech is a Health Tech & Life Sciences company specializing in digital medical diagnostics. The company has developed a clinically validated system that integrates EEG and fMRI data, leveraging artificial intelligence and machine learning to provide a neurodiagnostic solution for individuals with epilepsy. This technology also facilitates research into other brain disorders, serving the broader healthcare and life sciences sectors, including patients, providers, and the biotechnology and pharmaceutical industries.
Log in to access full profile ›Company Intelligence Q&A
- What is ELDA BrainTech's core technology?
- ELDA BrainTech's core technology is an AI-powered neurodiagnostic platform that combines EEG and fMRI data to provide solutions for epilepsy and facilitate research into other brain disorders.
- When was ELDA BrainTech founded?
- ELDA BrainTech was founded in November 2019.
- Who is a founder of ELDA BrainTech?
- Dan Shaham is a founder of ELDA BrainTech.
- What is ELDA BrainTech's primary market focus?
- ELDA BrainTech primarily focuses on the Health Tech & Life Sciences sector, specifically digital medical diagnostics for neurology patients, with an initial emphasis on epilepsy.
- Has ELDA BrainTech received any regulatory approvals?
- ELDA BrainTech has obtained FDA pre-submission approval for its medical diagnostic system.